ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.200
$0.170 (5.04%)
Day Range
$3.120 - $3.350
52 Week Range
$0.560 - $5.240
Volume
274.84K
Avg Volume (10D)
484.54K
Market Cap
$505.87M
Price Chart
Market Statistics
Open$3.350
Previous Close$3.370
Day High$3.350
Day Low$3.120
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap505.87M
Shares Outstanding158.08M
Price to Book5.66
Trading Activity
Volume274.84K
Value Traded880.35K
Bid$3.150 × 1,587
Ask$3.380 × 400
Performance
1 Day-5.04%
5 Day-5.88%
13 Week-18.78%
52 Week332.43%
YTD-32.06%
Technical Indicators
RSI (14)46.52
50-Day SMA$3.689
200-Day SMA$2.583
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
